This proposal will help identify the natural history of eosinophilic gastrointestinal disorders, identify prognostic and non-invasive biomarkers, establish research and treatment algorithms, evaluate new treatments, and support clinical trials and high risk–high return pilot studies. Furthermore, consortiums such as the one proposed can play a pivotal role in the training of physicians and investigators and educating the public and lay organizations about eosinophilic gastrointestinal diseases.
|Effective start/end date||8/15/14 → 7/31/19|
- Cincinnati Children's Hospital Medical Center (135407//1U54AI117804)
- National Institute of Allergy and Infectious Diseases (135407//1U54AI117804)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.